Dalit Tchorsh-Yutsis, Ph.D.
Affiliations: | 2010 | Weizmann Institute of Science, Rehovot, Israel |
Area:
Physiology Biology, Histology Biology, ImmunologyGoogle:
"Dalit Tchorsh-Yutsis"Parents
Sign in to add mentor| Yair Reisner | grad student | 2010 | Weizmann Institute | |
| (Stemness and Immunogenicity in Embryonic Development.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Aronovich A, Nur Y, Shezen E, et al. (2013) A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure. Blood. 122: 2562-71 |
| Tchorsh-Yutsis D, Zlotnikov Klionsky Y, Bachar-Lustig E, et al. (2011) Embryonic pig pancreatic tissue for the treatment of diabetes: potential role of immune suppression with "off-the-shelf" third-party regulatory T cells. Transplantation. 91: 398-405 |
| Cohen S, Tchorsh-Yutsis D, Aronovich A, et al. (2010) Growth enhancement by embryonic fibroblasts upon cotransplantation of noncommitted pig embryonic tissues with fully committed organs. Transplantation. 89: 1198-207 |
| Bachar-Lustig E, Tchorsh-Yutsis D, Ophir E, et al. (2010) Towards Clinically Feasible Co-Stimulatory Blockade for Tolerance Induction: Transient Treatment with CTLA4-Ig, Anti-CD48 and FTY720 Enables Durable Engraftment of T Cell Depleted BM Allografts Following Non-Myeloablative Conditioning. Blood. 116: 3726-3726 |
| Tchorsh-Yutsis D, Hecht G, Aronovich A, et al. (2009) Pig embryonic pancreatic tissue as a source for transplantation in diabetes: transient treatment with anti-LFA1, anti-CD48, and FTY720 enables long-term graft maintenance in mice with only mild ongoing immunosuppression. Diabetes. 58: 1585-94 |